Childhood absence epilepsy
ICD-10 G40.3 · ICD-11 8A61.21

Childhood Absence Epilepsy with Generalized Tonic-Clonic Seizures: What to Do After Lamotrigine Has Not Achieved Seizure Freedom

Clinical Scenario

This protocol applies to a child with childhood absence epilepsy (CAE) who has also experienced a generalized tonic-clonic seizure — a feature that directly shapes which treatments are appropriate and which prior options are insufficient.

Why This Protocol Is Needed — Prior Treatment Failure

⚠ Prior therapy did not achieve the target

Lamotrigine (LTG) monotherapy was trialled as the preceding line. Escalation to this protocol is indicated when the following goals were not achieved:

Treatment Approach — Partial Overview

The protocol for this situation involves either a two-agent combination therapy or an alternative monotherapy approach — the choice and full sequencing depend on patient-specific factors detailed in the structured regimen.

Complete dosing, titration schedules, monitoring criteria, and decision points are in the full protocol →

Goal: Freedom from absence seizures
Instant Access to Structured Evidence-Based Regimens

References

  1. VPA is the drug of choice as initial monotherapy in CAE when a generalized tonic–clonic seizure has occurred, because ETX is not effective against seizure types beyond absence seizures.
  2. Persistent seizures or AE on ETX, VPA and LTG monotherapy: Treat with combination of VPA and LTG, or consider clobazam.
  3. We recommend trying a combination of VPA and LTG.
  4. If LTG is not efficacious or only partly efficacious at this point, the next treatment to consider is clobazam.
View source ↗